Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening Products

California Warns Consumers Not To Eat Seng Chen PiMei Candy
Dr. Mark Horton, director of the California Department of Public Health (CDPH), warned consumers not to eat SENG Chen PiMei Candy, after tests by CDPH found unacceptable levels of lead. Consumers in possession of the candy should discard it immediately.
generic viagra online
California Primary Care Physician Shortage Affecting Clinics That Serve Minority Populations
A shortage of primary care physicians in California "is driving community clinics to find innovate ways" to provide care to an increasingly linguistically and culturally diverse patient population, New America Media reports. According to New America Media, primary care physicians are in short supply nationwide because many medical students are pursuing more lucrative specialty fields that have higher reimbursement rates. Marty Lynch -- executive director of LifeLong Medical Care, a not-for-profit primary health care facility that operates nine health centers in Berkeley, Oakland and Marin County -- said he has tried unsuccessfully to hire minority primary care physicians and nurses. Lynch said it is "very difficult to find primary care providers" to provide care for minorities. Meanwhile, the demand for health services is on the rise, Jane Garcia, CEO of La Clinica de la Raza, said. The clinic has provided health services in the Bay Area at 27 satellite clinics for 38 years.The clinic for the last two years has partnered with neighboring community colleges to train medical assistants to work at their clinics to meet demand for diverse staff. "We"re training our own community members," Garcia said. She added that in the current economy, the "silver lining" is that "health care is one of the few sectors that more people will be choosing careers in" (Sundaram, New America Media, 5/18).
News of the day
Sleep Laboratory Finds Insomnia With Short Sleep Duration Is A Risk Factor For Diabetes
Individuals with insomnia and objective short sleep duration are at increased risk for developing diabetes, according to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.
Diagnostics

Foresight Biotherapeutics Announces Positive Results From An Open Label Pilot Study In Patients With Viral Conjunctivitis

Foresight Biotherapeutics, Inc. announced completion of a multi-center open-label pilot study of FST100 in the treatment of viral conjunctivitis. FST-100 is a novel formulation of dexamethasone that includes povidone iodine. The trial studied patients with clinical signs and symptoms of acute conjunctivitis who tested positive for adenoviral antigen by the RPS Adeno Detector® (RPS). Patients were enrolled in a single arm utilizing FST-100 topical ophthalmic suspension given 4 times daily for 5 days. The RPS Adeno Detector® test was performed at baseline and at each visit along with conjunctival swabs for adenoviral titers by quantitative PCR (qPCR) and cell culture with confirmatory immunoflourescence (CC-IFA). The primary endpoint of the study was clinical resolution of conjunctival injection and conjunctival discharge. These signs were scored on a scale from zero to three. Secondary endpoints included reduction of viral titers measured by qPCR and eradication of infectious virus determined by CC-IFA. FST-100 met the primary endpoint of the study by demonstrating complete resolution of conjunctivitis signs (a score of zero) in all eyes completing the study. One patient was lost to follow-up. In all RPS positive eyes with confirmed viral infection by qPCR and CC-IFA clinical symptoms resolved within 72 hours. All eyes completing the study with detectable adenovirus by qPCR demonstrated significant reduction in viral titers by 48-96 hours and the majority demonstrated elimination of infectivity by CC-IFA by 72-96 hours. There were no adverse events in the study. Lead investigator Jesse Pelletier, M.D. commented, "We are excited about this preliminary data and look forward to enrolling patients in a larger controlled clinical study. Currently, there are no drugs approved for the treatment of viral conjunctivitis and it is certainly an area of unmet medical need." Foresight Biotherapeutics, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009